Plain-English translation of NCT06286267 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is building an artificial intelligence (AI) system designed to help doctors more accurately diagnose breast phyllodes tumors and predict which patients are at higher risk for the tumor returning or spreading. The AI system will combine information from medical images, tumor tissue samples, and genetic data to give doctors a better understanding of each patient's specific tumor and prognosis.
Phyllodes tumors are rare breast tumors that can be difficult to diagnose accurately using traditional methods, and some can come back or spread after treatment. Better tools to identify which patients are at highest risk would help doctors choose the right treatment and improve survival rates.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would allow the research team to access your medical records, tumor tissue samples, and imaging scans that have already been taken as part of your regular care. The researchers will use this information to train and test their AI system — you would not need to undergo any additional procedures or visits beyond your routine medical care.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China